Failure to Improve during First Day of Therapy Is Predictive of 28-Day Mortality in Severe Sepsi

Mitchell M. Levy; William L. Macias; James A. Russell; Mark D. Williams; Benjamin Trzaskoma; Eliezer Silva; Jean Louis Vincent

doi:10.1378/chest.124.4_meetingabstracts.120s

Related publications

Article2004

Endpoints in sepsis trials: More than just 28-day mortality?

Jean Louis Vincent

Article2007

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety

Pierre‐François Laterre, David R. Nelson, William L. Macias, Edward Abraham, Andreas Sashegyi, Mark D. Williams, Mitchell M. Levy, Marcel Levi, Barbara G. Utterback, Jean Louis Vincent

Article2014

Trends in 28‐day and 1‐year mortality rates in patients hospitalized for a first acute myocardial infarction in Norway during 2001–2009: a “Cardiovascular disease in Norway” (CVDNOR) project

Enxhela Sulo, Dan Joseph Stein, Ottar Nygård, Gerhard Sulo, Jannicke Igland, Grace M. Egeland, M. Ebbing, Grethe S. Tell

Article2023

PB0091 Fibrin Monomers Positivity During Hospitalization is a Good Predictive Marker of In-Hospital Mortality during COVID-19

David M. Smadja, David M. Smadja, Nicolas Gendron, Nicolas Gendron, Aurélien Philippe, Aurélien Philippe, Jean‐Luc Diehl, Jean‐Luc Diehl, N. Ochat, N. Ochat, Olivier Bory, Olivier Bory, A. Beauvais, A. Beauvais, Alexis Mareau, Alexis Mareau, Anne‐Sophie Jannot, Anne‐Sophie Jannot, Richard Chocron, Richard Chocron

Article2023

Fibrin monomers evaluation during hospitalization for COVID-19 is a predictive marker of in-hospital mortality

David M. Smadja, David M. Smadja, Nicolas Gendron, Nicolas Gendron, Aurélien Philippe, Aurélien Philippe, Jean‐Luc Diehl, Jean‐Luc Diehl, Nadège Ochat, Nadège Ochat, Olivier Bory, Olivier Bory, Agathe Beauvais, Agathe Beauvais, Alexis Mareau, Alexis Mareau, Anne‐Sophie Jannot, Anne‐Sophie Jannot, Richard Chocron, Richard Chocron